Batlle López, A., González de Villambrosía, S., Francisco, M., Malatxeberria, S., Sáez, A., Montalbán, C., . . . Montes Moreno, S. (2016). Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker.
Citación estilo ChicagoBatlle López, Ana, et al. Stratifying Diffuse Large B-cell Lymphoma Patients Treated With Chemoimmunotherapy: GCB/non-GCB By Immunohistochemistry Is Still a Robust and Feasible Marker. 2016.
Cita MLABatlle López, Ana, et al. Stratifying Diffuse Large B-cell Lymphoma Patients Treated With Chemoimmunotherapy: GCB/non-GCB By Immunohistochemistry Is Still a Robust and Feasible Marker. 2016.
Precaución: Estas citas no son 100% exactas.